Daré Bioscience, Inc. (DARE) NASDAQ

2.17

+0.01(+0.46%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap26.51M
Enterprise Value12.12M
P/E Ratio-1.58
PEG Ratio-0.13
Price/Sales Ratio-361.67
Price/Book Ratio9.68
Enterprise/Revenue-9.09
Enterprise/EBITDA-0.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin305.69
Operating Margin305.78

Management Effectiveness

Return On Assets-0.57
Return On Equity2.74

Income Statement

Revenue9,784
Revenue/Share-0
Gross Profit-14.3M
EBITDA-23.41M
Net Income-4.05M
Diluted EPS-0.48

Balance Sheet

Total Cash23.08M
Total Cash/Share1.81
Total Debt2.93M
Total Debt/Equity1.03
Current Ratio1.18
Book Value Per Share0.22

Price History

52-Week Change-32.19
52-Week High9.19
52-Week Low1.61
Moving Average 50 Days1.96
Moving Average 200 Days2.43

Statistics

Average Volume196,665
Shares Outstanding9.52M
% Held by Institutions11.38

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateJuly 01, 2024